Risk factors for new-onset diabetes after kidney transplantation

Nature Reviews Nephrology

Volumn 6, Issue 7, 2010, Pages 415-423

  Sharif, Adnan ^a   Baboolal, Keshwar ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL;

ABNORMAL SUBSTRATE CONCENTRATION IN BLOOD; AGE DISTRIBUTION; CLINICAL DECISION MAKING; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EDUCATIONAL STATUS; ETHNICITY; FAMILY HISTORY; GENETIC SUSCEPTIBILITY; GLOMERULUS FILTRATION RATE; GLUCOSE METABOLISM; HEPATITIS C; HLA MATCHING; HUMAN; HYPERGLYCEMIA; INNATE IMMUNITY; INSULIN RESISTANCE; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; METABOLIC DISORDER; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; SEX DIFFERENCE; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; DIABETES MELLITUS, TYPE 2; KIDNEY FAILURE, CHRONIC; POSTOPERATIVE COMPLICATIONS; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

DIABETES MELLITUS, TYPE 2; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 77954242160     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2010.66     Document Type: Review

References (88)

1. Saleem, T. F., Cunningham, K. E., Hollenbeak, C. S., Alfrey, E. J. & Gabbay, R. A. Development of diabetes mellitus post-renal transplantation is associated with poor shortterm clinical outcomes. Transplant. Proc. 35, 2916-2918 (2003).
2. Davidson, J. et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 75 (10 Suppl.), SS3-SS24 (2003).
3. Moore, R., Ravindran, v. & Baboolal, K. The burden of new-onset diabetes mellitus after transplantation. Clin. Transplant. 20, 755-761 (2006).
4. Burroughs, T. E. et al. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation 83, 1027-1034 (2007).
5. Cole, E. H., Johnston, O., Rose, C. L. & Gill, J. S. Impact of acute rejection and newonset diabetes on long-term transplant graft and patient survival. Clin. J. Am. Soc. Nephrol. 3, 814-821 (2008).
6. Revanur, v. K. et al. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin. Transplant. 15, 89-94 (2001).
7. Markell, M. New-onset diabetes mellitus in transplant patients: pathogenesis, complications, and management. Am. J. Kidney Dis. 43, 953-965 (2004).
8. de Mattos, A. M. et al. Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors. Kidney Int. 70, 757-764 (2006).
9. Cosio, F. G. et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int. 67, 2415-2421 (2005).
10. Kasiske, B. L., Guijarro, C., Massy, Z. A., Wiederkehr, M. R. & Ma, J. Z. Cardiovascular disease after renal transplantation. J. Am. Soc. Nephrol. 7, 158-165 (1996).
11. Kasiske, B. L. Epidemiology of cardiovascular disease after renal transplantation. Transplantation 72 (6 Suppl.), S5-S8 (2001).
12. van Hooff, J. P., Christiaans, M. H. & van Duijnhoven, E. M. Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol. Dial. Transplant. 19 (Suppl. 6), vi8-vi12 (2004).
13. Ekstrand, A. v., Eriksson, J. G., Gronhagen- Riska, C., Ahonen, P. J. & Groop, L. C. Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation 53, 563-569 (1992).
14. Kahn, S. E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46, 3-19 (2003).
15. Kasiske, B. L., Snyder, J. J., Gilbertson, D. & Matas, A. J. Diabetes mellitus after kidney transplantation in the United States. Am. J. Transplant. 3, 178-185 (2003).
16. Cosio, F. G., Pesavento, T. E., Osei, K., Henry, M. L. & Ferguson, R. M. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int. 59, 732-737 (2001).
17. Woodward, R. S. et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am. J. Transplant. 3, 590-598 (2003).
18. Gourishankar, S., Jhangri, G. S., Tonelli, M., Wales, L. H. & Cockfield, S. M. Development of diabetes mellitus following kidney transplantation: a Canadian experience. Am. J. Transplant. 4, 1876-1882 (2004).
19. Shah, T. et al. Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation 82, 1673-1676 (2006).
20. Hjelmesaeth, J. et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 64, 979-983 (1997).
21. Rodrigo, E. et al. New-onset diabetes after kidney transplantation: risk factors. J. Am. Soc. Nephrol. 17 (12 Suppl. 3), S291-S295 (2006).
22. McKeigue, P. M., Shah, B. & Marmot, M. G. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337, 382-386 (1991).
23. Sumrani, N. B. et al. Diabetes mellitus after renal transplantation in the cyclosporine era-an analysis of risk factors. Transplantation 51, 343-347 (1991).
24. Depczynski, B., Daly, B., Campbell, L. v., Chisholm, D. J. & Keogh, A. Predicting the occurrence of diabetes mellitus in recipients of heart transplants. Diabet. Med. 17, 15-19 (2000).
25. Hur, K. Y. et al. Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. Diabetes Care 30, 609-615 (2007).
26. de Mattos, A. M. et al. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney Int. 67, 714-720 (2005).
27. Ducloux, D. et al. Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus. Nephrol. Dial. Transplant. 14, 1244-1246 (1999).
28. Hamer, R. A., Chow, C. L., Ong, A. C. & McKane, W. S. Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation 83, 36-40 (2007).
29. Hjelmesaeth, J. & Hartmann, A. Insulin resistance in patients with adult polycystic kidney disease. Nephrol. Dial. Transplant. 14, 2521-2522 (1999).
30. Pietrzak-Nowacka, M. et al. Autosomal dominant polycystic kidney disease reduces the risk of diabetes mellitus. Arch. Med. Res. 37, 360-364 (2006).
31. Torres-Romero, L. F. et al. HLA is not predictive of posttransplant diabetes mellitus. Transplant. Proc. 38, 914-915 (2006).
32. Kang, E. S. et al. A variant of the transcription factor 7-like 2 (TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients. Diabetes Care 31, 63-68 (2008).
33. Bamoulid, J. et al. IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation. J. Am. Soc. Nephrol. 17, 2333-2340 (2006).
34. Zuber, J. et al. HNF1B-related diabetes triggered by renal transplantation. Nat. Rev. Nephrol. 5, 480-484 (2009).
35. Ibernon, M. et al. Low serum mannose-binding lectin as a risk factor for new onset diabetes mellitus after renal transplantation. Transplantation 88, 272-278 (2009).
36. Cervera, C. et al. The influence of innate immunity gene receptors polymorphisms in renal transplant infections. Transplantation 83, 1493-1500 (2007).
37. Bergrem, H. A. et al. Glucose tolerance before and after renal transplantation. Nephrol. Dial. Transplant. 25, 985-992 (2009).
38. Kim, C., Newton, K. M. & Knopp, R. H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25, 1862-1868 (2002).
39. Sharif, A. Metabolic syndrome and solid-organ transplantation. Am. J. Transplant. 10, 12-17 (2010).
40. Porrini, E. et al. Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation. Am. J. Kidney Dis. 48, 134-142 (2006).
41. Laclaustra, M., Corella, D. & Ordovas, J. M. Metabolic syndrome pathophysiology: the role of adipose tissue. Nutr. Metab. Cardiovasc. Dis. 17, 125-139 (2007).
42. Armstrong, K. A. et al. Free fatty acids are associated with obesity, insulin resistance, and atherosclerosis in renal transplant recipients. Transplantation 80, 937-944 (2005).
43. Bayes, B. et al. Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation. Am. J. Transplant. 7, 416-422 (2007).
44. Bayes, B. et al. Adiponectin and risk of newonset diabetes mellitus after kidney transplantation. Transplantation 78, 26-30 (2004).
45. Hjelmesaeth, J. et al. Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: impact of immunosuppressive and antihypertensive drug therapy. Clin. J. Am. Soc. Nephrol. 1, 575-582 (2006).
46. Prasad, G. V. et al. Reduced incidence of newonset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutarylcoenzyme a reductase inhibitors (statins). Am. J. Transplant. 4, 1897-1903 (2004).
47. Cosio, F. G. et al. Patient survival after renal transplantation: Iv. Impact of post-transplant diabetes. Kidney Int. 62, 1440-1446 (2002).
48. Porrini, E. et al. The combined effect of pretransplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation. Nephrol. Dial. Transplant. 23, 1436-1441 (2008).
49. Kelley, D. E. & Goodpaster, B. H. Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24, 933-941 (2001).
50. Hjelmesaeth, J. et al. Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage. Nephrol. Dial. Transplant. 20, 2311-2315 (2005).
51. Hjelmesaeth, J. et al. Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia 47, 1550-1556 (2004).
52. Smith, R. M. CMv prophylaxis: a useful step towards prevention of post-transplant diabetes? Diabetologia 47, 1473-1475 (2004).
53. Finni, P. E. et al. Is hepatitis C a risk factor to posttransplant diabetes mellitus after renal transplantation in patients using tacrolimus? Transplant. Proc. 36, 884-885 (2004).
54. Sens, Y. A. et al. Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus. Transplant. Proc. 36, 886-888 (2004).
55. Bloom, R. D. et al. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J. Am. Soc. Nephrol. 13, 1374-1380 (2002).
56. Baid-Agrawal, S. et al. Impaired insulin sensitivity as an underlying mechanism linking hepatitis C and posttransplant diabetes mellitus in kidney recipients. Am. J. Transplant. 9, 2777-2784 (2009).
57. Hill, C. M., Douglas, J. F., Rajkumar, K. v., McEvoy, J. & McGeown, M. G. Glycosuria and hyperglycaemia after kidney transplantation. Lancet 2, 490-492 (1974).
58. Hjelmesaeth, J. et al. Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance. Nephrol. Dial. Transplant. 16, 829-835 (2001).
59. Boots, J. M., Van Duijnhoven, E. M., Christiaans, M. H., Wolffenbuttel, B. H. & van Hooff, J. P. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J. Am. Soc. Nephrol. 13, 221-227 (2002).
60. Midtvedt, K. et al. Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J. Am. Soc. Nephrol. 15, 3233-3239 (2004).
61. Woodle, E. S. et al. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann. Surg. 248, 564-577 (2008).
62. Heisel, O., Heisel, R., Balshaw, R. & Keown, P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am. J. Transplant. 4, 583-595 (2004).
63. Montori, v. M. et al. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 25, 583-592 (2002).
64. Polastri, L. et al. Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells. Acta Diabetol. 39, 229-233 (2002).
65. van Hooff, J. P., Van Duijnhoven, E. M. & Christiaans, M. H. Tacrolimus and glucose metabolism. Transplant. Proc. 31, 49S-50S (1999).
66. vincenti, F. et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am. J. Transplant. 7, 1506-1514 (2007).
67. Bouchta, N. B. et al. Conversion from tacrolimus to cyclosporin is associated with a significant improvement of glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation. Transplant. Proc. 37, 1857-1860 (2005).
68. Butani, L. & Makker, S. P. Conversion from tacrolimus to neoral for postrenal transplant diabetes. Pediatr. Nephrol. 15, 176-178 (2000).
69. Oberholzer, J. et al. Immediate conversion from tacrolimus to cyclosporine in the treatment of posttransplantation diabetes mellitus. Transplant. Proc. 37, 999-1000 (2005).
70. Luan, F. L. et al. Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period. Am. J. Transplant. 8, 1871-1877 (2008).
71. Johnston, O., Rose, C. L., Webster, A. C. & Gill, J. S. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J. Am. Soc. Nephrol. 19, 1411-1418 (2008).
72. Teutonico, A., Schena, P. F. & Di Paolo, S. Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J. Am. Soc. Nephrol. 16, 3128-3135 (2005).
73. Thornley-Brown, D. et al. Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease. Arch. Intern. Med. 166, 797-805 (2006).
74. Hjelmesaeth, J., Midtvedt, K., Jenssen, T. & Hartmann, A. Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy. Diabetes Care 24, 2121-2126 (2001).
75. DREAM Trial investigators. Effect of ramipril on the incidence of diabetes. N. Engl. J. Med. 355, 1551-1562 (2006).
76. van Laecke, S. et al. Posttransplantation hypomagnesemia and its relation with immunosuppression as predictors of newonset diabetes after transplantation. Am. J. Transplant. 9, 2140-2149 (2009).
77. Barbagallo, M. & Dominguez, L. J. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch. Biochem. Biophys. 458, 40-47 (2007).
78. Dehghan, A., Van Hoek, M., Sijbrands, E. J., Hofman, A. & Witteman, J. C. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 31, 361-362 (2008).
79. Pittas, A. G. et al. vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29, 650-656 (2006).
80. Sharif, A. Predictors of new-onset diabetes after transplantation: the overlooked confounders. Am. J. Transplant. 9, 2858 (2009).
81. Sharif, A. Insulin, glucose, and glomerular filtration rate. Transplantation 87, 1592-1593 (2009).
82. Sharif, A. et al. Complex interplay between insulinemia, glycemia, and glomerular filtration rate in nondiabetic renal transplant recipients. Transplantation 88, 290-292 (2009).
83. Gerich, J. E., Meyer, C., Woerle, H. J. & Stumvoll, M. Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 24, 382-391 (2001).
84. Stumvoll, M., Meyer, C., Mitrakou, A., Nadkarni, v. & Gerich, J. E. Renal glucose production and utilization: new aspects in humans. Diabetologia 40, 749-757 (1997).
85. Meyer, C., Dostou, J. M. & Gerich, J. E. Role of the human kidney in glucose counterregulation. Diabetes 48, 943-948 (1999). (Pubitemid 29226338)
86. Sharif, A., Moore, R. H. & Baboolal, K. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: an underdiagnosed phenomenon. Transplantation 82, 1667-1672 (2006).
87. Sharif, A. & Baboolal, K. Diagnostic application of the A1C assay in renal disease. J. Am. Soc. Nephrol. 21, 383-385 (2010).
88. valderhaug, T. G. et al. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation 88, 429-434 (2009).